Until recently, a patent could only be obtained in Hong Kong if it was based on the registration of a patent granted in any one of China, Europe and the United Kingdom. This re-registration process occurred in two stages: 1. A request to record an application...

After a long wait, the Intellectual Property Laws Amendments (Productivity Commission Response Part 2 and Other Measures) Bill 2019 received Royal Assent on 26 February 2020 and will now be known as Intellectual Property Laws Amendments (Productivity Commission Response Part 2 and Other Measures) Act 2020...

The CRISPR/Cas9 gene editing system provides a precise, relatively simple and versatile method for editing DNA and, as such, has been hailed as the biggest biotech breakthrough of the 21st century. However, the European Patent Office (EPO) has now revoked one of the key, early patents...

MBIP succeeds in revoking a granted patent by strategic use of re-examination   When clients come to us to determine the best options for challenging a granted Australian patent, different considerations come into play. A challenger must evaluate the cost involved, the level of participation and rates...

At the beginning of June, Australian Patent Attorney Brendan Nugent will be visiting Philadelphia to attend the BIO International Convention. Brendan is a life sciences and chemistry patent specialist and has vast experience in preparing, filing and prosecuting patent applications in the field of biotechnology, pharmaceuticals...

Michael Buck IP is delighted to announce that Daniel Rosenthal has joined the growing Brisbane based intellectual property firm. Daniel is a seasoned patent attorney bringing over 20 years’ experience and high-level technical knowledge having worked in top intellectual property firms across two continents. Daniel holds a Bachelor of...

The Federal Court of Australia in Mylan Health Pty Ltd v Sun Pharma ANZ Pty Ltd [2019] FCA 28 has considered whether a generic manufacturer of a pharmaceutical product sold under a “skinny label” could be liable for indirect infringement of a patent. In this...

Translate »